Robinson Smith Wealth Advisors’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-953
Closed -$297K 92
2025
Q1
$297K Buy
953
+148
+18% +$43.7K 0.25% 66
2024
Q4
$210K Buy
805
+65
+9% +$19.3K 0.18% 76
2024
Q3
$238K Sell
740
-350
-32% -$114K 0.2% 75
2024
Q2
$341K Buy
+1,090
New +$320K 0.3% 62
2024
Q1
Sell
-1,105
Closed -$318K 80
2023
Q4
$318K Buy
+1,105
New +$301K 0.31% 63

Other funds holding AMGN

Robinson Smith Wealth Advisors's AMGN Position: Q2 2025 in Review

Robinson Smith Wealth Advisors sold out of Amgen (AMGN) in Q2 2025, closing a stake of 953 shares — an estimated $297K sold.

Robinson Smith Wealth Advisors first reported a position in AMGN in Q4 2023 and held it in 5 quarters. The position peaked at $341K in Q2 2024. 2,852 funds tracked by Wall St. Rank hold AMGN as of Q2 2025.

  • Robinson Smith Wealth Advisors reported no remaining Amgen position as of Q2 2025 after selling out during the quarter.
  • Robinson Smith Wealth Advisors sold 953 Amgen shares in Q2 2025, an estimated $297K.
  • Robinson Smith Wealth Advisors first reported a position in Amgen in Q4 2023 and held it in 5 quarters.
  • Robinson Smith Wealth Advisors's Amgen position peaked at $341K in Q2 2024.
  • 2,852 funds tracked by Wall St. Rank held Amgen as of Q2 2025.

Based on Robinson Smith Wealth Advisors's 13F filing for Q2 2025, filed 6 Aug 2025.